• Roche drops two Huntington’s programs after tominersen miss The Pharma Letter Fri, 10 Jul 2026 09:19:58 GMT
• uniQure (QURE) Stock Trades At A Premium After A 289% Return simplywall.st Thu, 09 Jul 2026 10:35:42 GMT
• UniQure soars as Cantor upgrades on plans to seek gene therapy nod MSN Thu, 09 Jul 2026 02:55:58 GMT
• uniQure N.V. (QURE) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Thu, 09 Jul 2026 00:28:00 GMT
• Uniqure Insider Sold Shares Worth $952,051, According to a Recent SEC Filing Moomoo Tue, 07 Jul 2026 21:52:34 GMT
• uniQure (QURE) CEO sells 21,082 shares after option exercise under 10b5-1 plan Stock Titan Tue, 07 Jul 2026 20:48:09 GMT
• QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 Stocktwits Tue, 07 Jul 2026 17:39:17 GMT
• qure jumps 20% – analysts upgrade stock on huntington’s disease therapy update, retail eyes $150 Stocktwits Sun, 05 Jul 2026 16:38:56 GMT
• uniqure n.v. focuses on gene therapies as sector sentiment stays cautious Ad-hoc-news.de Fri, 03 Jul 2026 14:28:34 GMT
• Uniqure Insider Sold Shares Worth $983,030, According to a Recent SEC Filing Moomoo Thu, 02 Jul 2026 21:03:56 GMT
• uniQure (QURE) CMO sells 30,000 shares and exercises 10,000 stock options Stock Titan Thu, 02 Jul 2026 21:00:25 GMT
• uniQure (QURE) director sells 21,167 shares after exercising options Stock Titan Thu, 02 Jul 2026 20:55:02 GMT
• UniQure (NASDAQ: QURE) affiliate plans 21,082-share option sale; June open-market sales listed Stock Titan Thu, 02 Jul 2026 20:00:40 GMT
• qure stock just shot up 8% - uniqure’s much-talked-about huntington’s disease therapy gets a uk boost Stocktwits Thu, 02 Jul 2026 17:45:07 GMT
• fda lets uniqure seek accelerated approval for huntington's therapy, shares skyrocket MSN Thu, 02 Jul 2026 08:23:50 GMT
• precision trading with uniqure n.v. (qure) risk zones Stock Traders Daily Thu, 02 Jul 2026 04:12:02 GMT
• uniQure (QURE) Now Trades Above Golden Cross: Time to Buy? Zacks Investment Research Wed, 01 Jul 2026 13:03:41 GMT
• the other shoe drops: uniqure shares plans to submit licensing application with the fda for amt-130 HDBuzz Wed, 01 Jul 2026 08:55:09 GMT
• form 144 uniqure n.v. for: 30 june by investing.com Investing.com Nigeria Tue, 30 Jun 2026 21:19:39 GMT
• uniQure (QURE) CMO auto-sells shares for RSU tax withholding, keeps stake Stock Titan Tue, 30 Jun 2026 21:07:20 GMT
• UniQure (NASDAQ: QURE) insider notice to sell 21,167 shares Stock Titan Tue, 30 Jun 2026 20:01:12 GMT
• Sharing data for daily Huntington's pill, Skyhawk 'super encouraged' by FDA flexibility FirstWord Pharma Tue, 30 Jun 2026 19:17:32 GMT
• qure investor alert: bronstein, gewirtz and grossman, llc announc The National Law Review Tue, 30 Jun 2026 17:34:28 GMT
• Skyhawk CEO hopes FDA’s new uniQure position will translate to Huntington’s pill BioSpace Tue, 30 Jun 2026 11:02:14 GMT
• uniQure N.V. (QURE) Investors: Kessler Topaz Meltzer & Check, LLP The National Law Review Tue, 30 Jun 2026 10:37:10 GMT
• Enterprise value to EBITDA forward of uniQure N.V. – NASDAQ:QURE TradingView Tue, 30 Jun 2026 09:52:42 GMT
• UniQure (NASDAQ: QURE) files Form 144 to sell 30,000 shares via Citigroup Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Enterprise value to revenue forward of uniQure N.V. – NASDAQ:QURE TradingView Tue, 30 Jun 2026 06:24:10 GMT
• qure maintained by hc wainwright & co. -- price target raised to $80 GuruFocus Mon, 29 Jun 2026 12:11:03 GMT
• uniqure's $259m raise: a strategic bet on gene therapy's future BriefGlance Mon, 29 Jun 2026 05:40:29 GMT
• uniQure (QURE) Closed A Major Funding Round, Is The Pipeline Already Priced In? simplywall.st Sun, 28 Jun 2026 09:18:41 GMT
• form 144 uniqure n.v. for: 26 june by investing.com Investing.com Nigeria Sat, 27 Jun 2026 03:02:22 GMT
• Enterprise value to EBIT forward of uniQure N.V. – NASDAQ:QURE TradingView Fri, 26 Jun 2026 13:02:18 GMT
• uniqure epilepsy gene therapy data draws investor focus Streetwise Reports Fri, 26 Jun 2026 09:45:15 GMT
• gene therapy co. announces initial data for refractory epilepsy treatment gets buy rating Streetwise Reports Fri, 26 Jun 2026 09:45:15 GMT
• uniQure (QURE) Is Up 6.1% After Equity Raise And FDA Backing For Accelerated HD Filing - Has The Bull Case Changed? simplywall.st Fri, 26 Jun 2026 07:00:00 GMT
• UniQure (QURE) files Rule 144 to sell 22,402 RSU shares; prior 45,000 sold Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• uniQure (QURE) CEO Kapusta sells 35K shares after exercising options Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• qure jumps 20% – analysts upgrade stock on huntington’s disease therapy update, retail eyes $150 Stocktwits Fri, 26 Jun 2026 06:30:59 GMT
• uniqure closes $259m public offering at $45.50 per share by investing.com Investing.com South Africa Fri, 26 Jun 2026 01:16:11 GMT
• enterprise value to revenue forward of uniqure n.v. – lsx:a1xdtv TradingView Thu, 25 Jun 2026 23:03:32 GMT
• uniqure announces closing of upsized public offering and full exercise by underwriters of option to purchase additional shares The Manila Times Thu, 25 Jun 2026 20:20:19 GMT
• uniqure's $259m raise: a strategic bet on gene therapy's future BriefGlance Thu, 25 Jun 2026 20:10:00 GMT
• enterprise value to ebitda forward of uniqure n.v. – lsx:a1xdtv TradingView Thu, 25 Jun 2026 17:34:50 GMT
• uniqure (qure) reports early amt 260 data with seizure reduction in epilepsy Sahm Thu, 25 Jun 2026 10:06:35 GMT
• FDA’s uniQure, REGENXBIO reversals could bolster other near-term rare disease applications BioSpace Thu, 25 Jun 2026 07:00:00 GMT
• UniQure N.V. (QURE) Upgraded to Overweight as Huntington’s Disease Program Advances Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• uniQure Closes $259 Million Public Offering of Ordinary Shares Quiver Quantitative Thu, 25 Jun 2026 07:00:00 GMT
• Mizuho raises uniQure stock price target to $68 on FDA meeting optimism Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• uniQure closes $259M public offering at $45.50 per share Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• Kapusta (QURE) sells 28,716 shares after option exercise on 06/25/2026 Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• morgan lewis advises uniqure on $259m follow-on offering – news Morgan Lewis Thu, 25 Jun 2026 07:00:00 GMT
• mizuho securities maintains uniqure nv(qure.us) with buy rating, raises target price to $68 Moomoo Thu, 25 Jun 2026 00:31:00 GMT
• uniqure completes upsized public equity offering for growth TipRanks Wed, 24 Jun 2026 21:29:29 GMT
• uniqure prices $45.50 stock offering; underwriting with leerink partners nets $242.7 million TradingView Wed, 24 Jun 2026 21:03:01 GMT
• uniqure (nasdaq: qure) prices $225m underwritten share offering Stock Titan Wed, 24 Jun 2026 20:54:48 GMT
• 5 best healthcare stocks to buy according to wall street analysts Insider Monkey Wed, 24 Jun 2026 17:41:56 GMT
• uniqure n.v. (qure) prices $225m public offering of shares GuruFocus Wed, 24 Jun 2026 17:06:21 GMT
• what’s next in line for fda reversals after uniqure and regenxbio Seeking Alpha Wed, 24 Jun 2026 16:38:33 GMT
• uniqure n.v. (qure) stock dips following $225m share offering announcement Blockonomi Wed, 24 Jun 2026 15:29:34 GMT
• uniqure prices $225 million ordinary stock offering marketscreener.com Wed, 24 Jun 2026 07:59:14 GMT
• uniqure prices $225m public offering to fund gene therapy advancements Pluang Wed, 24 Jun 2026 07:48:55 GMT
• uniQure Announces Pricing of $225 Million Public Offering of Ordinary Shares Quiver Quantitative Wed, 24 Jun 2026 07:00:00 GMT
• uniQure (NASDAQ: QURE) files Rule 144 resale notice listing recent insider sales Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• uniQure (NASDAQ: QURE) raises $211.5M net to fund AMT-130 launch plans Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• uniQure (QURE) Reports Early AMT 260 Data With Seizure Reduction In Epilepsy simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• UniQure (QURE) Gains Regulatory Support from FDA Under New Leade GuruFocus Wed, 24 Jun 2026 07:00:00 GMT
• uniqure (qure) shares climb 7.6% with notable price increase GuruFocus Wed, 24 Jun 2026 06:09:41 GMT
• uniqure prices $225m public offering at $45.50 per share Investing.com Wed, 24 Jun 2026 01:52:15 GMT
• all securities to be sold in offering are being sold by uniqure >qure Moomoo Wed, 24 Jun 2026 01:27:00 GMT
• uniqure: granted the underwriters 30-day option to purchase up to 741,758 additional shares at public offering price >qure Moomoo Wed, 24 Jun 2026 01:27:00 GMT
• uniqure's $225m boost: fueling a new era for gene therapy innovation BriefGlance Wed, 24 Jun 2026 01:13:55 GMT
• uniqure announces pricing of upsized $225 million public offering Yahoo Finance Wed, 24 Jun 2026 01:13:00 GMT
• gene therapy amt-260 shows early seizure reductions in refractory mesial temporal lobe epilepsy, phase 1 cohort data show NeurologyLive Tue, 23 Jun 2026 22:16:07 GMT
• qure stock soars as fda backs accelerated huntington’s therapy path timothysykes.com Tue, 23 Jun 2026 21:05:00 GMT
• UniQure to seek AMT-130 approval as FDA agrees on path for drug huntingtonsdiseasenews.com Tue, 23 Jun 2026 19:24:24 GMT
• qure stock roars as fda clears faster path for amt-130 StocksToTrade Tue, 23 Jun 2026 16:33:00 GMT
• uniqure (qure) shares climb 7.6% with notable price increase GuruFocus Tue, 23 Jun 2026 16:04:26 GMT
• uniqure commences $150 million public offering of shares Investing.com UK Tue, 23 Jun 2026 09:13:10 GMT
• uniqure's experimental drug shows early promise in difficult-to-treat epilepsy Sahm Tue, 23 Jun 2026 08:31:57 GMT
• uniQure (QURE) Launches $150M Public Offering Amid After-Hours D GuruFocus Tue, 23 Jun 2026 07:51:03 GMT
• uniQure Announces Pricing of Upsized $225 Million Public Offering Sahm Tue, 23 Jun 2026 07:00:00 GMT
• Huntington’s Gene Therapy Back on Track to File for FDA Approval Being Patient Tue, 23 Jun 2026 05:03:30 GMT
• analysts are bullish on top healthcare stocks: clearpoint neuro (clpt), uniqure (qure) The Globe and Mail Tue, 23 Jun 2026 02:38:00 GMT
• uniqure announces planned $150 million public offering marketscreener.com Mon, 22 Jun 2026 20:17:16 GMT
• uniqure starts $150m share sale, with $22.5m extra option Stock Titan Mon, 22 Jun 2026 20:03:47 GMT
• uniqure announces $150 million proposed public offering GlobeNewswire Mon, 22 Jun 2026 20:01:00 GMT
• uniqure’s $150m gamble: funding hope after a regulatory windfall BriefGlance Mon, 22 Jun 2026 20:01:00 GMT
• uniqure's experimental drug shows early promise in difficult-to-treat epilepsy Benzinga Mon, 22 Jun 2026 15:51:29 GMT
• REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot BioSpace Mon, 22 Jun 2026 14:39:49 GMT
• in another reversal for rare disease field, fda to reconsider regenxbio gene therapy Fierce Biotech Mon, 22 Jun 2026 14:26:41 GMT
• uniqure n.v. insider sold shares worth $9,371,612, according to a recent sec filing marketscreener.com Mon, 22 Jun 2026 12:59:52 GMT
• uniqure (qure) ceo sells 206,100 shares and exercises stock options Stock Titan Mon, 22 Jun 2026 12:31:27 GMT
• uniqure n.v. insider sold shares worth $526,485, according to a recent sec filing Moomoo Mon, 22 Jun 2026 12:13:55 GMT
• form 8k uniqure n.v. for: 22 june by investing.com Investing.com Nigeria Mon, 22 Jun 2026 11:33:40 GMT
• uniqure (qure) secures fda reversal for huntington's disease gen GuruFocus Mon, 22 Jun 2026 11:29:05 GMT
• uniqure reports preliminary amt-260 phase i/iia low-dose results; 3 of 6 patients show 79–100% seizure reduction TradingView Mon, 22 Jun 2026 10:53:00 GMT
• uniQure (NASDAQ: QURE) seeks $150M in equity and pre-funded warrants ahead of AMT-130 BLA Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• uniQure (QURE) shows mixed but promising early AMT-260 MTLE results Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• uniQure (QURE) director Jack Kaye sells shares after exercising stock options Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• uniQure (QURE) director exercises 11,685 options, sells shares under 10b5-1 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• uniqure’s chronic epilepsy gene therapy ‘should be on investors’ radar’ BioSpace Mon, 22 Jun 2026 07:00:00 GMT
• uniqure commences $150 million public offering of shares Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• gene therapy for huntington's disease faces new regulatory hurdle Neurology Today Mon, 22 Jun 2026 04:30:05 GMT
• qure jumps 20% – analysts upgrade stock on huntington’s disease therapy update, retail eyes $150 Stocktwits Sun, 21 Jun 2026 11:02:31 GMT
• qure stock just shot up 8% - uniqure’s much-talked-about huntington’s disease therapy gets a uk boost Stocktwits Sun, 21 Jun 2026 07:10:37 GMT
• neurologylive®'s conference coverage, oveporexton displays symptom improvement in nt1, fda allows bla for amt-130 in hd NeurologyLive Sat, 20 Jun 2026 20:15:09 GMT
• fda lets uniqure seek accelerated approval for huntington's therapy, shares skyrocket MSN Sat, 20 Jun 2026 08:59:30 GMT
• uniqure (qure) stock could be 12% undervalued after fda backs amt 130 filing path simplywall.st Sat, 20 Jun 2026 07:00:00 GMT
• qure soars as fda backs amt-130 data for accelerated approval TradingView Fri, 19 Jun 2026 18:19:00 GMT
• uniqure announces preliminary data on first cohort in phase i/iia clinical trial of amt-260 TradingView Fri, 19 Jun 2026 14:39:33 GMT
• uniqure reports mixed results from epilepsy gene therapy trial Investing.com UK Fri, 19 Jun 2026 13:44:46 GMT
• cell therapy weekly: bla submission planned for huntington’s gene therapy amt-130 RegMedNet Fri, 19 Jun 2026 11:08:38 GMT
• why uniqure (qure) is up 72.9% after fda backs amt-130 data for accelerated approval prospects simplywall.st Fri, 19 Jun 2026 08:05:05 GMT
• uniQure Announces Preliminary Data on the First Cohort in GlobeNewswire Fri, 19 Jun 2026 07:00:00 GMT
• Weekly Rundown: uniQure will seek approval for Huntington's disease gene therapy after switchup at FDA Drug Discovery News Fri, 19 Jun 2026 07:00:00 GMT
• uniQure (QURE) Stock Sees Fair Value Lift As AMT 130 BLA Plans Rework Risk Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
• uniQure’s epilepsy gene therapy showed seizure drops in 3 patients Stock Titan Fri, 19 Jun 2026 07:00:00 GMT
• uniqure (qure) stock could be 49% undervalued after fda amt 130 update Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
• uniqure (qure) is up 67.9% after fda backs amt-130 data for accelerated approval path Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
uniQure N.V(NASDAQ:QURE) 
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also e...
Website: http://www.uniqure.com
Founded: 1998
Full Time Employees: 248
Sector: Healthcare
Industry: Biotechnology